Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Jade Biosciences, Inc. (JBIO) had Free Cash Flow per Share of $-28.82 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-2.52M |
|
-- |
|
-- |
|
$3.39M |
|
$-3.39M |
|
$0.87M |
|
$-2.52M |
|
$-2.52M |
|
$-2.52M |
|
$-2.52M |
|
$-2.52M |
|
$-2.52M |
|
$-3.39M |
|
$-3.61M |
|
0.08M |
|
0.08M |
|
$-3.16 |
|
$-3.16 |
|
| Balance Sheet Financials | |
$77.37M |
|
$0.00M |
|
$0.16M |
|
$77.53M |
|
$2.42M |
|
-- |
|
$0.07M |
|
$2.49M |
|
$75.05M |
|
$75.05M |
|
$75.05M |
|
0.83M |
|
| Cash Flow Statement Financials | |
$-2.38M |
|
$12.85M |
|
-- |
|
$33.75M |
|
$44.22M |
|
$10.47M |
|
$1.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
32.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.38M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-3.36% |
|
-3.36% |
|
-3.25% |
|
-3.36% |
|
$90.85 |
|
|
Free Cash Flow per Share |
$-28.82 |
$-28.82 |
|